Results 181 to 190 of about 2,446,622 (333)
Assessment of the abstract reporting of systematic reviews of dose-response meta-analysis: a literature survey [PDF]
Pengli Jia +8 more
openalex +1 more source
A Systematic Survey of Automatic Loan Approval System Based on Machine Learning
Vandana Sharma, Rewa Sharma
openalex +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
COVID-19 retracted publications on retraction watch: A systematic survey of their pre-prints and citations. [PDF]
Syed Z, Syed F, Thabane L, Rodrigues M.
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
A Systematic Survey of Research Trends in Technology Usage for Parkinson's Disease. [PDF]
Deb R, An S, Bhat G, Shill H, Ogras UY.
europepmc +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
Myxedema coma: challenges and future directions, a systematic survey and review. [PDF]
Zhang Y, Chu L, Han H.
europepmc +1 more source
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source

